Mylan's Stock Is No Longer A Buy According To Analysts At Argus By: Benzinga via Benzinga August 22, 2017 at 09:07 AM EDT Analysts at Argus no longer hold a bullish view on Mylan N.V. (NASDAQ: MYL) after the company cut its full-year guidance and cautioned ... Read More >> Related Stocks: Adamis Pharmaceuticl Mylan Sanofi-Aventis S.A. ADR